123 related articles for article (PubMed ID: 3089538)
21. Origin of insulin-receptive nerve terminals in rat median eminence.
van Houten M; Nance DM; Gauthier S; Posner BI
Endocrinology; 1983 Oct; 113(4):1393-9. PubMed ID: 6617575
[TBL] [Abstract][Full Text] [Related]
22. The effect of arcuate nucleus transplantation on the development of the anterior pituitary in monosodium glutamate-treated rats.
Inoue H; Kohsaka S; Otani M; Toya S; Tsukada Y
Neurosci Res; 1986 Sep; 3(6):555-67. PubMed ID: 3095715
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus.
Merchenthaler I; Vigh S; Schally AV; Petrusz P
Endocrinology; 1984 Apr; 114(4):1082-5. PubMed ID: 6423368
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of hypothalamic deafferentation upon luteinizing hormone-releasing hormone in the median eminence and organum vasculosum of the lamina terminalis.
Weiner RI; Pattou E; Kerdelhue B; Kordon C
Endocrinology; 1975 Dec; 97(6):1597-600. PubMed ID: 1107018
[TBL] [Abstract][Full Text] [Related]
25. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone releasing factor immunoreactivity in rat hypothalamus.
Smith RM; Howe PR; Oliver JR; Willoughby JO
Neuropeptides; 1984 Mar; 4(2):109-15. PubMed ID: 6425712
[TBL] [Abstract][Full Text] [Related]
27. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
Antoni FA; Kanyicska B; Makara GB
J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
[TBL] [Abstract][Full Text] [Related]
28. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
[TBL] [Abstract][Full Text] [Related]
29. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats.
Wakabayashi I; Hatano H; Minami S; Tonegawa Y; Akira S; Sugihara H; Ling NC
Brain Res; 1986 May; 372(2):361-5. PubMed ID: 3085872
[TBL] [Abstract][Full Text] [Related]
30. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
Spinedi E; Johnston C; Negro-Vilar A
Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
[TBL] [Abstract][Full Text] [Related]
31. The preoptico-infundibular LH-RH tract of the rat.
Merchenthaler I; Kovács G; Lavász G; Sétáló G
Brain Res; 1980 Sep; 198(1):63-74. PubMed ID: 6996789
[TBL] [Abstract][Full Text] [Related]
32. The luteinizing hormone-releasing hormone (LH-RH) neuronal networks of the guinea pig brain. II. The regulation on gonadotropin secretion and the origin of terminals in the median eminence.
Krey LC; Silverman AJ
Brain Res; 1978 Nov; 157(2):247-55. PubMed ID: 363242
[TBL] [Abstract][Full Text] [Related]
33. Regional distribution of rat growth hormone releasing factor-like immunoreactivity in rat hypothalamus.
Kita T; Chihara K; Abe H; Minamitani N; Kaji H; Kodama H; Kashio Y; Okimura Y; Fujita T; Ling N
Endocrinology; 1985 Jan; 116(1):259-62. PubMed ID: 3917250
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Doi N; Hirotani C; Ukai K; Shimada O; Okuno T; Kurasaki S; Kiyofuji T; Ikegami R; Futamata M; Nakagawa T; Ase K; Chihara K
Arzneimittelforschung; 2004; 54(12):857-67. PubMed ID: 15646370
[TBL] [Abstract][Full Text] [Related]
35. [Interrelations between monoamines and luliberin in the synaptosomes of the medio-basal hypothalamus and its separate structures].
Babichev VN; Ozol' LIu; Markarian RL; El'tseva TV
Probl Endokrinol (Mosk); 1985; 31(5):36-41. PubMed ID: 3906634
[TBL] [Abstract][Full Text] [Related]
36. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
Soya H; Suzuki M
Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
[TBL] [Abstract][Full Text] [Related]
37. Exogenous glutamate enhances glutamate receptor subunit expression during selective neuronal injury in the ventral arcuate nucleus of postnatal mice.
Hu L; Fernstrom JD; Goldsmith PC
Neuroendocrinology; 1998 Aug; 68(2):77-88. PubMed ID: 9705574
[TBL] [Abstract][Full Text] [Related]
38. Substance P and substance K in the rat hypothalamus following monosodium glutamate lesions of the arcuate nucleus.
Jessop DS; Chowdrey HS; Biswas S; Lightman SL
Neuropeptides; 1991 Mar; 18(3):165-70. PubMed ID: 1712432
[TBL] [Abstract][Full Text] [Related]
39. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback.
Advis JP; McCann SM; Negro-Vilar A
Endocrinology; 1980 Oct; 107(4):892-901. PubMed ID: 6997020
[TBL] [Abstract][Full Text] [Related]
40. Identification of growth hormone-releasing hormone and somatostatin neurons projecting to the median eminence in normal and growth hormone-deficient Ames dwarf mice.
Romero MI; Phelps CJ
Neuroendocrinology; 1997 Feb; 65(2):107-16. PubMed ID: 9067988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
